Ubs Group Ag Grove, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	N/A	500 New	500 $1,000
Q1 2023 May 12, 2023	BUY	N/A	556 Added 911.48%	617 $2,000
Q4 2022 Feb 08, 2023	SELL	N/A	-3,388 Reduced 98.23%	61 $0
Q3 2022 Nov 10, 2022	BUY	$3.93 - $6.08 $11,180 - $17,297	2,845 Added 471.03%	3,449 $13,000
Q2 2022 Aug 10, 2022	BUY	$4.01 - $5.85 $2,422 - $3,533	604 New	604 $3,000
Q4 2021 Feb 14, 2022	SELL	$3.9 - $7.64 $11,232 - $22,003	-2,880 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.06 - $6.8 $9,009 - $15,089	2,219 Added 335.7%	2,880 $15,000
Q2 2021 Aug 13, 2021	BUY	$5.6 - $7.86 $3,701 - $5,195	661 New	661 $4,000

Others Institutions Holding GRVI

# of Institutions

11

Shares Held

788K

Call Options Held

0

Put Options Held

0

About GROVE, INC.

Ticker GRVI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,819,800
Market Cap $83.3M

More about GRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.